Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
New words:
answer, antitrust, Bayview, BESP, broker, clearance, deliverable, denied, elicit, eligible, Genome, GSK, heard, inactivated, infection, Japanese, lease, linked, Live, methodology, model, optimize, Pasteur, policy, publicly, quote, Sanofi, satisfaction, SE, tied, unethical, upfront, Valneva, waiting, ZIKV
Filing tables
Filing exhibits
Related press release
EBS similar filings
Filing view
External links
EXHIBIT 12
Ratio of Earnings to Fixed Charges | |||||||||||||||||||||||
Year to Date | |||||||||||||||||||||||
June 30, | Year Ended December 31, | ||||||||||||||||||||||
(in thousands) | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||||
Pretax income from continuing operations (1) | $ | 20,366 | $ | 99,221 | $ | 135,716 | $ | 84,194 | $ | 83,439 | $ | 68,011 | |||||||||||
Fixed charges | |||||||||||||||||||||||
Interest expense | 3,814 | 8,270 | 7,834 | 7,480 | 1,973 | 2,177 | |||||||||||||||||
Debt issuance cost | 763 | 1,526 | 1,564 | 3,290 | 319 | 67 | |||||||||||||||||
Total fixed charges (2) | 4,577 | 9,796 | 9,398 | 10,770 | 2,292 | 2,244 | |||||||||||||||||
Noncontrolling interest in pretax income (3) | - | - | - | - | 876 | 5,381 | |||||||||||||||||
Capitalized interest (4) | 834 | 2,179 | 2,875 | 2,530 | 1,973 | 2,177 | |||||||||||||||||
Earnings ((1) + (2) -(3) -(4)) | 24,109 | 106,838 | 142,239 | 92,434 | 82,882 | 62,697 | |||||||||||||||||
Fixed charges | 4,577 | 9,796 | 9,398 | 10,770 | 2,292 | 2,244 | |||||||||||||||||
Ratio of earnings to fixed charges | 5.3 | 10.9 | 15.1 | 8.6 | 36.2 | 27.9 |